This compound is not intended to diagnose, treat, cure, or prevent any disease
A Certificate of Analysis (CoA) is issued per production lot and is available on request before purchase or with the shipment
TB-500 Injections: Injectable formulations allow for precise dosage control, enabling adjustments based on individual requirements or desired effects
not for human or veterinary use Key Characteristics of AOD 9604 (3mg) Defined growth hormone fragment: A 16amino-acid segment from the C-terminal region of human growth hormone, used to study metabolism-focused activity in research models
The subset D50D53 focuses specifically on anemias caused by nutritional deficiencies or impaired red blood cell production
In a 2024 review of three peptides, the FDA noted side effects like increased heart rate, chest tightening, headache, nausea, diarrhea, and elevated liver enzymes, as well as skin irritation and pain at the injection site